These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14568335)

  • 1. The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade.
    Starowicz K; Sieja A; Bilecki W; Obara I; Przewlocka B
    Brain Res; 2003 Nov; 990(1-2):113-9. PubMed ID: 14568335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of morphine tolerance by spinal melanocortin receptor blockade.
    Starowicz K; Obara I; Przewłocki R; Przewlocka B
    Pain; 2005 Oct; 117(3):401-411. PubMed ID: 16153779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala.
    Maj M; Turchan J; Smiałowska M; Przewłocka B
    Neuropeptides; 2003 Apr; 37(2):105-10. PubMed ID: 12747942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
    Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
    Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
    Alvaro JD; Tatro JB; Quillan JM; Fogliano M; Eisenhard M; Lerner MR; Nestler EJ; Duman RS
    Mol Pharmacol; 1996 Sep; 50(3):583-91. PubMed ID: 8794897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
    Song SH; Takemori AE
    Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats.
    Cui XY; Lundeberg T; Yu LC
    Brain Res; 2004 Jan; 995(1):23-8. PubMed ID: 14644467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain.
    Vrinten DH; Gispen WH; Kalkman CJ; Adan RA
    Anesthesiology; 2003 Aug; 99(2):449-54. PubMed ID: 12883419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.
    Vergoni AV; Bertolini A; Wikberg JE; Schiöth HB
    Peptides; 1999; 20(4):509-13. PubMed ID: 10458522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice.
    Ercil NE; Galici R; Kesterson RA
    Psychopharmacology (Berl); 2005 Jul; 180(2):279-85. PubMed ID: 15719225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of CRF and dopamine receptors in amygdala for reinforcing effects of opiates and opioids on self-stimulation of lateral hypothalamus in rats].
    Shabanov PD; Lebedev AA; Liubimov AV; Kornilov VA
    Eksp Klin Farmakol; 2011; 74(7):3-8. PubMed ID: 21894759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S
    Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
    Skelton KH; Oren D; Gutman DA; Easterling K; Holtzman SG; Nemeroff CB; Owens MJ
    Eur J Pharmacol; 2007 Sep; 571(1):17-24. PubMed ID: 17610870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system.
    Meuser T; Giesecke T; Gabriel A; Horsch M; Sabatowski R; Hescheler J; Grond S; Palmer PP
    Anesth Analg; 2003 Nov; 97(5):1458-1463. PubMed ID: 14570665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala.
    Sepehrizadeh Z; Sahebgharani M; Ahmadi S; Shapourabadi MB; Bozchlou SH; Zarrindast MR
    Pharmacology; 2008; 81(4):333-43. PubMed ID: 18391508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain - a biochemical and behavioral study.
    Starowicz K; Mousa SA; Obara I; Chocyk A; Przewłocki R; Wedzony K; Machelska H; Przewłocka B
    Pharmacol Rep; 2009; 61(6):1086-95. PubMed ID: 20081244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin 4 receptor antagonists attenuates morphine antinociceptive tolerance, astroglial activation and cytokines expression in the spinal cord of rat.
    Niu Z; Ma J; Chu H; Zhao Y; Feng W; Cheng Y
    Neurosci Lett; 2012 Nov; 529(2):112-7. PubMed ID: 23022502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.